Diagnostic Imaging Research Seminar Series

---

RSS

Occurs every 3 months on the 3rd Thursday starting on 1/19/2023 at 12:00 PM
Thursday, January 19, 2023, 12:00 PM - 1:00 PM, Virtual


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

This series will provide physicians, physicists, and trainees a forum to discuss new operational and emerging cutting edge procedures. In addition, professionals will be able to define indications, contraindications, and outcomes including complications resulting from new technologies used on patients undergoing staging of a disease, resulting in better patient outcomes. Information will also be presented on how to perform appropriate analysis and draw appropriate conclusions from data acquired in imaging studies.

1. Identify, discuss and understand new diagnostic and imaging technology.
2. Describe and discuss new operational and emerging cutting edge procedures.
3. Define indications, contraindications, and outcomes including complications resulting from new technologies used on patients undergoing staging of a disease, resulting in better patient outcomes.
4. Perform appropriate analysis and draw appropriate conclusions from data acquired in imaging studies.

This is closed, invitation only. For more information, contact Kimberly White  at [email protected]

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.